Spinwheel is revolutionizing the consumer credit ecosystem. The company partners with lenders, marketplaces and personal financial management platforms to provide real-time, verified consumer credit data to process payments as part of their clients’ existing workflow and operations via APIs and its agentic AI platform.
Status: Private
dataplor
dataplor provides point-of-interest (POI) data for businesses across the economy for geospatial analyses, operational workflows, and growth initiatives. The company’s data service is refreshed regularly with rigorous quality checks, and goes far beyond basic business names and addresses, enriching each location with brand, transaction, persona, foot-traffic estimates, hours of operation, sentiment scores, popularity metrics, and more, providing an unmatched combination of depth, breadth, and global coverage.
LeadIQ
LeadIQ is a workflow centric lead data and sales prospecting SaaS platform focused on enterprise and mid-market clients. LeadIQ allows users to research and capture potential leads easily, enrich leads with further details, and integrates into various sales acceleration and customer management platforms like Salesloft, Outreach, Hubspot and Salesforce.
An Eight Roads investment. Eight Roads is F-Prime’s sister venture capital investment group, with which F-Prime collaborates on investments outside of the Americas and Europe.
Roark
Roark automates the creation of voice agent test suites from real customer journeys and AI-driven edge-case predictions, so businesses can validate every path before deployment and ship reliable voice AI faster.
Myolab
Myolab builds personalized human digital twins with embodied intelligence to accurately predict an individual’s physiology, cognition, and behavior, and enable hyper-personalized experiences in health, search, and e-commerce.
Cartesian Kinetics
Cartesian Kinetics provides fast, retrofittable, Goods to Person automation solutions using its proprietary platform Carte+. Carte+ enables efficient and reliable order fulfillment to cope with increasingly on-demand consumption patterns. Cartesian Kinetics is headquartered in the US and has teams across multiple locations in the US and Bangalore, India.
Candid
Candid is a developer of teeth alignment technology designed to offer hassle-free dental alignment service. The company’s technology offers a digital platform for teeth aligners, made of Bisphenol A free plastic that won’t irritate cheeks and gums like traditional braces often do, enabling users to straighten and brighten teeth with non-irritant orthodontist-designed custom clear aligners.
Axle Health
Axle Health is a healthcare technology company on a mission to revolutionize home-based care delivery through its comprehensive operations platform. Founded in 2020 by healthcare and technology veterans, including several former Uber executives who brought their logistics expertise to the healthcare industry, Axle Health’s AI-powered logistics platform enables healthcare organizations to efficiently deploy clinicians for in-home visits, improving patient outcomes while reducing operational costs. The company is headquartered in Los Angeles, California.
Countable Labs
Countable Labs is redefining PCR with single-molecule precision and category-defining sensitivity, overcoming the limitations of legacy technologies. Countable PCR delivers 10 times the sensitivity and precision of digital PCR in a single reaction. Plus, it speeds up assay development with simplified multiplexing. These breakthroughs unlock high-sensitivity applications that were previously impractical due to cost and complexity.
Peptone
Peptone is an innovative drug discovery company applying advanced biophysics, atomic-level experimental approaches, cutting-edge supercomputing and machine learning to the challenge of biopharmaceutical research and development. By bringing these proprietary approaches together, Peptone is exploring the world of intrinsically disordered proteins (IDPs) – proteins without a fixed structure that play a significant role in health and disease – opening up the possibility of novel therapeutics against this class of high value and previously undruggable targets.